These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8538290)

  • 1. [Connection between levonorgestrel-IUD and GAS (Group A Streptococcus) sepsis? Reliable risk assessment is not yet possible].
    Milsom I; Landgren BM; Alestig K
    Lakartidningen; 1995 Dec; 92(50):4781-2. PubMed ID: 8538290
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case report. Sepsis in connection with levonorgestrel IUD].
    Ottander U; Bäckström T; Högberg U; Löfgren M
    Lakartidningen; 1995 Nov; 92(48):4555-7. PubMed ID: 7490972
    [No Abstract]   [Full Text] [Related]  

  • 3. Group A streptococcus necrotising fasciitis from a levonorgestrel-containing intrauterine system ('Mirena' coil).
    Saleh S; Ahmad G; Majumdar A
    J Obstet Gynaecol; 2011; 31(2):192-4. PubMed ID: 21281048
    [No Abstract]   [Full Text] [Related]  

  • 4. Levonorgestrel intrauterine device (IUD) exacerbation of PMS symptoms.
    Appiani FJ; Carroll BT
    Ann Clin Psychiatry; 2014 May; 26(2):146-7. PubMed ID: 24812652
    [No Abstract]   [Full Text] [Related]  

  • 5. IUDs and ectopic pregnancy.
    Sivin I
    Contraception; 1995 Nov; 52(5):321-2. PubMed ID: 8585891
    [No Abstract]   [Full Text] [Related]  

  • 6. Streptococcal Toxic Shock Syndrome After Insertion of a Levonorgestrel Intrauterine Device.
    Balayla J; Gil Y; Mattina J; Al-Shehri E; Ziegler C
    J Obstet Gynaecol Can; 2019 Dec; 41(12):1772-1774. PubMed ID: 30981616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair loss with use of the levonorgestrel intrauterine device.
    Paterson H; Clifton J; Miller D; Ashton J; Harrison-Woolrych M
    Contraception; 2007 Oct; 76(4):306-9. PubMed ID: 17900442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system.
    Karri K; Mowbray D; Adams S; Rendal JR
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):53-4. PubMed ID: 16546818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel-releasing intrauterine device and uterine perforations.
    Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and use of an intrauterine levonorgestrel-releasing device.
    Vos AG; van de Ree MA
    Neth J Med; 2012 Nov; 70(9):431. PubMed ID: 23123543
    [No Abstract]   [Full Text] [Related]  

  • 11. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
    Neven P; Amant F; Poppe W; Van den Broecke R
    Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
    [No Abstract]   [Full Text] [Related]  

  • 12. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
    Boutet G
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exercise-induced oedema due to hormone-containing intrauterine device].
    Franssen LE; Bos WJ
    Ned Tijdschr Geneeskd; 2012; 156(45):A4978. PubMed ID: 23134748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-decidual reaction to Mirena coil in a cervical smear: a potential diagnostic pitfall for false-positive cervical cytology.
    Hughes C; Woods J; Turner L; Gibbons D
    Cytopathology; 2005 Oct; 16(5):268-9. PubMed ID: 16181320
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel intrauterine device: new preparation. An alternative.
    Prescrire Int; 1999 Dec; 8(44):175-7. PubMed ID: 11503815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the levonorgestrel-releasing intrauterine system and breast cancer.
    Tjalma WA; Trinh XB; van Dam PA
    Obstet Gynecol; 2006 Jan; 107(1):207-8; author reply 208. PubMed ID: 16394064
    [No Abstract]   [Full Text] [Related]  

  • 19. Levonorgestrel-releasing intrauterine system causes a lichenoid drug eruption.
    Jones JA; Shuler MJ; Zlotoff BJ
    Cutis; 2015 Jul; 96(1):E13-5. PubMed ID: 26244359
    [No Abstract]   [Full Text] [Related]  

  • 20. Endometrial adenocarcinoma in association with a levonorgestrel-releasing intrauterine system (Mirena).
    Ndumbe FM; Husemeyer RP
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):113-4. PubMed ID: 16824305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.